EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Enzalutamide and Quality of Life in Biochemically Recurrent Prostate Cancer

Stephen J Freedland, Martin Gleave, Ugo De Giorgi, Antti Rannikko, Christopher M Pieczonka, Ronald F Tutrone, Balaji Venugopal, Henry H Woo, Miguel Ramirez-Backhaus, Stephane Supiot, Anna Lantz, Arijit Ganguli und 5 weitere

NEJM Evidence · 2023

DOI: 10.1056/evidoa2300251 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift NEJM Evidence, 2023. Verfasst von Stephen J Freedland und 16 weiteren Autor:innen. Beteiligte Einrichtung: Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles. Hauptthemen laut MEDLINE: Quality of Life, Prostatic Neoplasms, Castration-Resistant, Benzamides, Nitriles. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeProstatic Neoplasms, Castration-ResistantBenzamidesNitrilesMaleHumansLeuprolidePhenylthiohydantoin

Substanzen

enzalutamideLeuprolidePhenylthiohydantoinBenzamidesNitriles

Autor:innen und Institutionen

  • Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles.
  • Veterans Affairs Health Care System, Durham, NC.
  • The Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
  • IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Italy.
  • Department of Urology and Research Program in Systems Oncology, University of Helsinki, Helsinki.
  • Helsinki University Hospital, Helsinki.

Zitieren

APA

Freedland, S. J., Gleave, M., De Giorgi, U., Rannikko, A., Pieczonka, C. M., Tutrone, R. F., Venugopal, B., Woo, H. H., Ramirez-Backhaus, M., Supiot, S., Lantz, A., Ganguli, A., Ivanova, J., Kral, P., Huang, S. P., Saad, F., & Shore, N. D. (2023). Enzalutamide and Quality of Life in Biochemically Recurrent Prostate Cancer. NEJM Evidence. https://doi.org/10.1056/evidoa2300251

Vancouver

Freedland SJ, Gleave M, De Giorgi U, Rannikko A, Pieczonka CM, Tutrone RF, et al. Enzalutamide and Quality of Life in Biochemically Recurrent Prostate Cancer. NEJM Evidence. 2023. doi:10.1056/evidoa2300251

BibTeX
@article{Freedland2023,
  author = {Freedland, Stephen J and Gleave, Martin and De Giorgi, Ugo and Rannikko, Antti and Pieczonka, Christopher M and Tutrone, Ronald F and Venugopal, Balaji and Woo, Henry H and Ramirez-Backhaus, Miguel and Supiot, Stephane and Lantz, Anna and Ganguli, Arijit and Ivanova, Jasmina and Kral, Pavol and Huang, Shu-Pin and Saad, Fred and Shore, Neal D},
  title = {Enzalutamide and Quality of Life in Biochemically Recurrent Prostate Cancer},
  journal = {NEJM Evidence},
  year = {2023},
  doi = {10.1056/evidoa2300251}
}
Kostenlos starten →